Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK.
Bioorg Med Chem Lett. 2010 Aug 15;20(16):4951-4. doi: 10.1016/j.bmcl.2010.05.018. Epub 2010 Jun 25.
A series of analogues of the pyrazole lead 1 were synthesized in which the heterocyclic core was replaced with an imidazole. A number of potent antagonists were identified and structure-activity relationships (SAR) were investigated both with respect to activity at the P2X(7) receptor and in vitro metabolic stability. Compound 10 was identified as a potent P2X(7) antagonist with reduced in vitro metabolism and high solubility.
一系列吡唑先导化合物 1 的类似物被合成,其中杂环核心被咪唑取代。鉴定出了一些有效的拮抗剂,并研究了它们在 P2X(7)受体上的活性以及体外代谢稳定性方面的构效关系(SAR)。化合物 10 被鉴定为一种有效的 P2X(7)拮抗剂,具有降低的体外代谢和高溶解度。